MHC class I polypeptide-related sequence B shedding modulates pancreatic tumor immunity via the activation of NKG2DLow T cells
Abstract Natural killer group 2 member D ligands (NKG2DLs) are expressed as stress response proteins in cancer cells. NKG2DLs induce immune cell activation or tumor escape responses, depending on their expression. Human pancreatic cancer cells, PANC-1, express membrane MHC class I polypeptide-relate...
| Published in: | Scientific Reports |
|---|---|
| Main Authors: | Hitoshi Toyoda, Atsuo Kuramasu, Masahiro Hosonuma, Masakazu Murayama, Yoichiro Narikawa, Junya Isobe, Yuta Baba, Kohei Tajima, Eiji Funayama, Midori Shida, Yuki Maruyama, Aya Sasaki, Yuya Hirasawa, Toshiaki Tsurui, Hirotsugu Ariizumi, Tomoyuki Ishiguro, Risako Suzuki, Sei Kobayashi, Atsushi Horiike, Noriko Hida, Takehiko Sambe, Koji Nobe, Satoshi Wada, Hitome Kobayashi, Mayumi Tsuji, Shinichi Kobayashi, Takuya Tsunoda, Yoshifumi Kudo, Yuji Kiuchi, Kiyoshi Yoshimura |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-73712-1 |
Similar Items
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01)
by: Elitsa Boneva, et al.
Published: (2025-03-01)
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
by: Ana Stojanovic, et al.
Published: (2018-04-01)
by: Ana Stojanovic, et al.
Published: (2018-04-01)
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01)
by: Ge Tan, et al.
Published: (2023-08-01)
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)
by: Jagoda Siemaszko, et al.
Published: (2021-06-01)
Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions
by: Caterina Marangio, et al.
Published: (2025-05-01)
by: Caterina Marangio, et al.
Published: (2025-05-01)
INHIBITION OF THE NKG2D ACTIVATING RECEPTOR EXPRESSION ON CYTOTOXIC LYMPHOCYTES BY RECOMBINANT MICA PROTEIN
by: E. V. Abakushina, et al.
Published: (2017-01-01)
by: E. V. Abakushina, et al.
Published: (2017-01-01)
NKG2D Ligand Shedding in Response to Stress: Role of ADAM10
by: Alessandra Zingoni, et al.
Published: (2020-03-01)
by: Alessandra Zingoni, et al.
Published: (2020-03-01)
NKG2D and Its Ligands: “One for All, All for One”
by: Alessandra Zingoni, et al.
Published: (2018-03-01)
by: Alessandra Zingoni, et al.
Published: (2018-03-01)
Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response
by: Stipan eJonjic
Published: (2011-12-01)
by: Stipan eJonjic
Published: (2011-12-01)
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)
by: Jagoda Siemaszko, et al.
Published: (2023-10-01)
A Herpesviral induction of RAE-1 NKG2D ligand expression occurs through release of HDAC mediated repression
by: Trever T Greene, et al.
Published: (2016-11-01)
by: Trever T Greene, et al.
Published: (2016-11-01)
The role of selected NKG2DLs such as MICA, MICB and ULBP4 as potential markers in multiple sclerosis
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01)
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-07-01)
Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
by: Adeline Raynaud, et al.
Published: (2021-01-01)
by: Adeline Raynaud, et al.
Published: (2021-01-01)
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology
by: Florencia Secchiari, et al.
Published: (2022-12-01)
by: Florencia Secchiari, et al.
Published: (2022-12-01)
Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4
by: Tobias Zöller, et al.
Published: (2018-03-01)
by: Tobias Zöller, et al.
Published: (2018-03-01)
KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP
by: Reem Alkhayer, et al.
Published: (2023-05-01)
by: Reem Alkhayer, et al.
Published: (2023-05-01)
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses
by: Thornton W Thompson, et al.
Published: (2017-12-01)
by: Thornton W Thompson, et al.
Published: (2017-12-01)
Romidepsin Enhances the Killing Ability of NKG2D-CAR-T Cells through Enhanced Expression of NKG2DL against Ovarian Cancer Cells
by: Liang Wang, et al.
Published: (2022-09-01)
by: Liang Wang, et al.
Published: (2022-09-01)
NKG2D-CAR memory T cells target pediatric T-cell acute lymphoblastic leukemia in vitro and in vivo but fail to eliminate leukemia initiating cells
by: Marta Ibáñez-Navarro, et al.
Published: (2023-10-01)
by: Marta Ibáñez-Navarro, et al.
Published: (2023-10-01)
Ectopic ULBP2 Is Associated with Decreased NKG2D Expression in CD8<sup>+</sup> T Cells Under T Cell-Modulatory Conditions in a Murine Tumor Model
by: Yasuhiko Teruya, et al.
Published: (2025-06-01)
by: Yasuhiko Teruya, et al.
Published: (2025-06-01)
Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro
by: Mahdi Zarei, et al.
Published: (2023-10-01)
by: Mahdi Zarei, et al.
Published: (2023-10-01)
Responsiveness to Influenza Vaccination Correlates with NKG2C-Expression on NK Cells
by: Peggy Riese, et al.
Published: (2020-06-01)
by: Peggy Riese, et al.
Published: (2020-06-01)
Экспериментальное исследование функциональной активности химерного антигенного рецептора NKG2D in vitro и in vivo
by: Ксения Александровна Левчук, et al.
Published: (2022-10-01)
by: Ксения Александровна Левчук, et al.
Published: (2022-10-01)
Designs of NKG2D-based immunotherapeutics for cancer
by: Jianfeng Han, et al.
Published: (2025-06-01)
by: Jianfeng Han, et al.
Published: (2025-06-01)
Leveraging NKG2D Ligands in Immuno-Oncology
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)
by: Mercedes Beatriz Fuertes, et al.
Published: (2021-07-01)
CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells
by: Xin Jin, et al.
Published: (2023-12-01)
by: Xin Jin, et al.
Published: (2023-12-01)
Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma
by: Junchen Liu, et al.
Published: (2025-01-01)
by: Junchen Liu, et al.
Published: (2025-01-01)
Increased proliferative response of highly differentiated CD57<sup>+</sup>NKG2C<sup>+</sup>NK cells expressing NKG2A
by: N. A. Alekseeva, et al.
Published: (2024-09-01)
by: N. A. Alekseeva, et al.
Published: (2024-09-01)
Diethyldithiocarbamate-copper complex ignites the tumor microenvironment through NKG2D-NKG2DL axis
by: Daciana C. Dumut, et al.
Published: (2025-02-01)
by: Daciana C. Dumut, et al.
Published: (2025-02-01)
Molecular bases for the regulation of NKG2D ligands in cancer
by: Leticia eHuergo-Zapico, et al.
Published: (2014-03-01)
by: Leticia eHuergo-Zapico, et al.
Published: (2014-03-01)
MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors
by: Elisha R. Verhaar, et al.
Published: (2024-03-01)
by: Elisha R. Verhaar, et al.
Published: (2024-03-01)
AID‐expressing epithelium is protected from oncogenic transformation by an NKG2D surveillance pathway
by: Arantxa Pérez‐García, et al.
Published: (2015-08-01)
by: Arantxa Pérez‐García, et al.
Published: (2015-08-01)
POTENTIAL USAGE OF NK CELLS AND NKG2D-POSITIVE LYMPHOCYTES AS TARGETS IN THERAPY OF CROHN’S DISEASE
by: E. A. Shulenina, et al.
Published: (2017-08-01)
by: E. A. Shulenina, et al.
Published: (2017-08-01)
The current state of knowledge on the role of NKG2D ligands in multiple sclerosis and other autoimmune diseases
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-01-01)
by: Aleksandra Pogoda-Wesołowska, et al.
Published: (2025-01-01)
Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
by: Steven T. Cox, et al.
Published: (2018-06-01)
by: Steven T. Cox, et al.
Published: (2018-06-01)
Highlighting a New Potential Target in Stroke: Immunoreceptor NKG2D
by: Josef Anrather, et al.
Published: (2023-06-01)
by: Josef Anrather, et al.
Published: (2023-06-01)
Downregulation of NKG2DLs by TGF-β in human lung cancer cells
by: Young Shin Lee, et al.
Published: (2021-07-01)
by: Young Shin Lee, et al.
Published: (2021-07-01)
Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease
by: Daniel Fernández-Soto, et al.
Published: (2024-02-01)
by: Daniel Fernández-Soto, et al.
Published: (2024-02-01)
Harnessing NKG2D CAR-T cells with radiotherapy: a novel approach for esophageal squamous cell carcinoma treatment
by: Tianyu Liu, et al.
Published: (2025-05-01)
by: Tianyu Liu, et al.
Published: (2025-05-01)
Isolation of a cytolytic subpopulation of extracellular vesicles derived from NK cells containing NKG7 and cytolytic proteins
by: Miriam Aarsund, et al.
Published: (2022-09-01)
by: Miriam Aarsund, et al.
Published: (2022-09-01)
Similar Items
-
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
by: Elitsa Boneva, et al.
Published: (2025-03-01) -
The NKG2D/NKG2DL Axis in the Crosstalk Between Lymphoid and Myeloid Cells in Health and Disease
by: Ana Stojanovic, et al.
Published: (2018-04-01) -
The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
by: Ge Tan, et al.
Published: (2023-08-01) -
NKG2D Natural Killer Cell Receptor—A Short Description and Potential Clinical Applications
by: Jagoda Siemaszko, et al.
Published: (2021-06-01) -
Exploring the dynamic of NKG2D/NKG2DL axis: A central regulator of NK cell functions
by: Caterina Marangio, et al.
Published: (2025-05-01)
